Literature DB >> 10704789

Carrier-enhanced human growth hormone absorption across isolated rabbit intestinal tissue.

G M Mlynek1, L J Calvo, J R Robinson.   

Abstract

Small molecular weight alpha acid derivatives are able to enhance the intestinal absorption of human growth hormone through isolated rabbit intestinal tissue. The enhancement is not through the usual tissue modification associated with traditional penetration enhancers nor is it through an active transport process. Rather these small molecules associate with human growth hormone in solution to make it more transportable through intestinal tissue. It is shown that the enhancer has specificity for a particular protein and the enhancer and human growth hormone must be in solution together to be effective, i.e. pretreating the tissue with enhancer and then adding the protein does not increase tissue permeability. Moreover, the enhancer does not increase the permeability of mannitol or progesterone, thus providing additional evidence of specificity and establishing that these agents are not classical penetration enhancers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704789     DOI: 10.1016/s0378-5173(99)00322-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Influence of food intake on the bioavailability and efficacy of oral calcitonin.

Authors:  Morten A Karsdal; Inger Byrjalsen; Möise Azria; Michel Arnold; Les Choi; Bente J Riis; Claus Christiansen
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

Review 2.  Lessons learned from the clinical development of oral peptides.

Authors:  Morten Asser Karsdal; Bente Juul Riis; Nozer Mehta; William Stern; Ehud Arbit; Claus Christiansen; Kim Henriksen
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

3.  Oral absorption enhancement of cromolyn sodium through noncovalent complexation.

Authors:  Xuan Ding; Parshuram Rath; Robert Angelo; Thomas Stringfellow; Elizabeth Flanders; Steven Dinh; Isabel Gomez-Orellana; Joseph R Robinson
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

4.  Oral heparin: status review.

Authors:  Ehud Arbit; Michael Goldberg; Isabel Gomez-Orellana; Shingai Majuru
Journal:  Thromb J       Date:  2006-05-10

5.  Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin.

Authors:  M A Karsdal; I Byrjalsen; B J Riis; C Christiansen
Journal:  BMC Clin Pharmacol       Date:  2008-12-04

Review 6.  A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives.

Authors:  Abdul Muheem; Faiyaz Shakeel; Mohammad Asadullah Jahangir; Mohammed Anwar; Neha Mallick; Gaurav Kumar Jain; Musarrat Husain Warsi; Farhan Jalees Ahmad
Journal:  Saudi Pharm J       Date:  2014-06-16       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.